Get the Stockscreener App
24.19
9.06%
-2.41
Newamsterdam Pharma Company Nv stock is traded at $24.19, with a volume of 1.18M.
It is down -9.06% in the last 24 hours and down -3.24% over the past month.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
See More
Previous Close:
$26.60
Open:
$26.19
24h Volume:
1.18M
Relative Volume:
1.29
Market Cap:
$2.72B
Revenue:
$14.09M
Net Income/Loss:
$-176.94M
P/E Ratio:
-11.25
EPS:
-2.15
Net Cash Flow:
$-141.24M
1W Performance:
-10.41%
1M Performance:
-3.24%
6M Performance:
+3.55%
1Y Performance:
+51.19%
1-Day Range:
$24.19
$26.67
1-Week Range:
$24.18
$27.35
52-Week Range:
$14.06
$27.35
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
Name
Newamsterdam Pharma Company Nv
Sector
Industry
Phone
35 206 2971
Address
GOOIMEER 2-35, NARRDEN
Compare NAMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAMS
Newamsterdam Pharma Company Nv
|
24.19 | 3.03B | 14.09M | -176.94M | -141.24M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Initiated | Wells Fargo | Overweight |
| Jul-17-25 | Initiated | Goldman | Neutral |
| Jun-17-25 | Initiated | Citigroup | Buy |
| Jun-10-25 | Initiated | Stifel | Buy |
| Jun-04-25 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-30-24 | Initiated | H.C. Wainwright | Buy |
| May-15-24 | Initiated | TD Cowen | Buy |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Jan-18-24 | Initiated | Guggenheim | Buy |
| Jan-16-24 | Initiated | Piper Sandler | Overweight |
| Oct-30-23 | Initiated | RBC Capital Mkts | Outperform |
View All
Newamsterdam Pharma Company Nv Stock (NAMS) Latest News
NewAmsterdam Pharma (NASDAQ:NAMS) Sees Unusually-High Trading Volume on Insider Buying Activity - MarketBeat
Louise Frederika Kooij Sells 150,000 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock - MarketBeat
Market reaction to NewAmsterdam Pharma Company N.V. Equity Warrant’s recent newsPortfolio Return Report & Detailed Earnings Play Alerts - Newser
Insider Buying: NewAmsterdam Pharma (NASDAQ:NAMS) Director Purchases 1,260 Shares of Stock - MarketBeat
Is it time to cut losses on NewAmsterdam Pharma Company N.V. Equity WarrantDip Buying & Advanced Swing Trade Entry Alerts - Newser
Risk vs reward if holding onto NewAmsterdam Pharma Company N.V. Equity WarrantRecession Risk & Safe Entry Trade Signal Reports - Newser
Alliancebernstein L.P. Acquires 383,888 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
What’s next for NewAmsterdam Pharma Company N.V. Equity Warrant stock price2025 Technical Patterns & Real-Time Buy Signal Notifications - Newser
When is the best time to exit NewAmsterdam Pharma Company N.V. Equity Warrant2025 Price Action Summary & High Return Trade Guides - Newser
NewAmsterdam Pharma Company N.V. stock outlook for YEAR2025 Analyst Calls & Capital Protection Trading Alerts - Newser
Leading vs lagging indicators on NewAmsterdam Pharma Company N.V. performanceEntry Point & Stepwise Trade Signal Implementation - Newser
What to expect from NewAmsterdam Pharma Company N.V. Equity Warrant in the next 30 daysRate Cut & Safe Entry Point Identification - Newser
What earnings revisions data tells us about NewAmsterdam Pharma Company N.V. Equity WarrantMarket Growth Report & Fast Momentum Stock Entry Tips - Newser
Technical signs of recovery in NewAmsterdam Pharma Company N.V. Equity Warrant2025 AllTime Highs & Advanced Swing Trade Entry Alerts - Newser
Analyzing drawdowns of NewAmsterdam Pharma Company N.V. with statistical toolsEarnings Miss & Expert Verified Movement Alerts - Newser
NewAmsterdam Pharma stock hits 52-week high at 27.35 USD By Investing.com - Investing.com Nigeria
Parkman Healthcare Partners LLC Purchases 24,839 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma Company N.V.’s volatility index tracking explainedWeekly Stock Summary & Capital Efficient Trading Techniques - Newser
What candlestick patterns are forming on NewAmsterdam Pharma Company N.V.July 2025 Big Picture & Growth Focused Stock Reports - Newser
Trexquant Investment LP Acquires Shares of 66,102 NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma stock hits 52-week high at 27.35 USD - Investing.com
Woodline Partners LP Acquires 11,615 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
Newamsterdam Pharma CAO Kooij sells $3.8m in shares By Investing.com - Investing.com Nigeria
Topper, director at NewAmsterdam Pharma, buys $31,487 in shares - Investing.com India
Topper, director at NewAmsterdam Pharma, buys $31,487 in shares By Investing.com - Investing.com Nigeria
Newamsterdam Pharma CAO Kooij sells $3.8m in shares - Investing.com
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Down 9.7% Following Insider Selling - MarketBeat
NewAmsterdam Pharma Company N.V. $NAMS Stock Holdings Lowered by Cutter Capital Management LP - MarketBeat
NewAmsterdam Pharma Company N.V. $NAMS Shares Bought by Adage Capital Partners GP L.L.C. - MarketBeat
NewAmsterdam Pharma Company N.V. Equity Warrant Stock Recovery Path — Analyst BreakdownJuly 2025 Update & Fast Momentum Entry Tips - beatles.ru
Resistance Break Could Fuel NewAmsterdam Pharma Company N.V. RallyJuly 2025 Spike Watch & Weekly Top Stock Performers List - beatles.ru
Published on: 2025-09-08 18:06:34 - beatles.ru
NewAmsterdam Pharma Company N.V. Equity Warrant Inches Toward Key Resistance — Will It BreakInflation Watch & Reliable Momentum Entry Alerts - beatles.ru
NewAmsterdam Pharma Company N.V.’s Price Action Aligns with Quant Signals2025 Bull vs Bear & Smart Swing Trading Alerts - beatles.ru
Published on: 2025-09-08 11:30:48 - beatles.ru
BVF Inc. IL Acquires Shares of 59,065 NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
RA Capital Management L.P. Acquires 1,293,938 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
Best data tools to analyze NewAmsterdam Pharma Company N.V. stock2025 Geopolitical Influence & Intraday High Probability Alerts - Newser
Is NewAmsterdam Pharma Company N.V. Equity Warrant on track to beat earningsJuly 2025 PostEarnings & Target Return Focused Picks - خودرو بانک
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
What’s the outlook for NewAmsterdam Pharma Company N.V.’s sector2025 Sector Review & Daily Chart Pattern Signals - خودرو بانک
Is NewAmsterdam Pharma Company N.V. subject to activist investor interestEarnings Growth Report & High Conviction Buy Zone Picks - خودرو بانک
Can NewAmsterdam Pharma Company N.V. Equity Warrant reach resistance levels soon2025 Buyback Activity & Precise Trade Entry Recommendations - خودرو بانک
Can NewAmsterdam Pharma Company N.V. Equity Warrant weather a recessionWeekly Investment Recap & Daily Price Action Insights - خودرو بانک
Can trapped investors hope for a rebound in NewAmsterdam Pharma Company N.V.July 2025 Institutional & Intraday High Probability Alerts - Newser
What’s the MACD signal for NewAmsterdam Pharma Company N.V. Equity Warrant2025 Key Highlights & Real-Time Price Movement Reports - خودرو بانک
Will NewAmsterdam Pharma Company N.V. rebound enough to break evenEarnings Miss & Community Supported Trade Ideas - Newser
How to build a custom watchlist for NewAmsterdam Pharma Company N.V. Equity Warrant2025 Volume Leaders & Accurate Technical Buy Alerts - Newser
What to do if you’re stuck in NewAmsterdam Pharma Company N.V. Equity WarrantEarnings Growth Summary & Expert Curated Trade Setup Alerts - Newser
What are the future prospects of NewAmsterdam Pharma Company N.V.Weekly Trade Report & AI Forecasted Stock Moves - خودرو بانک
Can swing trading help recover from NewAmsterdam Pharma Company N.V. Equity Warrant lossesJuly 2025 Technicals & Community Supported Trade Ideas - Newser
Newamsterdam Pharma Company Nv Stock (NAMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):